ALKS Stock Recent News
ALKS LATEST HEADLINES
The latest trading day saw Alkermes (ALKS) settling at $26.70, representing a -1.26% change from its previous close.
The quest for prime biotech stocks for gains will always be relevant. Moreover, 2024 promises a surge in technology and science, positioning biotech firms at the forefront of novel medical breakthroughs.
The latest trading day saw Alkermes (ALKS) settling at $26.94, representing a -0.41% change from its previous close.
Looking for pharma stocks to buy in February 2024? The pharmaceutical industry has always drawn a big crowd of investors.
Alkermes (ALKS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Alkermes (ALKS) closed the most recent trading day at $27.74, moving -1% from the previous trading session.
Alkermes (ALKS) reachead $27.92 at the closing of the latest trading day, reflecting a +1.34% change compared to its last close.
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock?
Alkermes' (ALKS) growth is being driven by the sale of its proprietary products, Vivitrol, Aristada and Lybalvi. However, stiff competition in the target market remains an overhang.
In the evolving stock market landscape, identifying growth stocks to buy that promise resilience and prosperity over the long haul is akin to finding treasures in a rough, dusty terrain. This article will delve into the trajectories of three standout companies poised to dominate the coming decade.